Aggression and schizophrenia: Efficacy of risperidone

Peter F. Buckley, Zafar Y. Ibrahim, Beth Singer, Bruce Orr, Karl Donenwirth, Parminder S. Brar

Research output: Contribution to journalArticle

74 Scopus citations

Abstract

The advent of novel antipsychotic medications has raised treatment expectations for patients with severe mental illness. In this regard, clozapine has been particularly effective in reducing aggressive behavior in patients with schizophrenia. This study compared the efficacy of risperidone and conventional antipsychotic medications in the management of hostile patients. Improvements in the level of aggression were evident over time in both treatment groups, and a similar response between risperidone and typical antipsychotics was observed. Future studies should address the relative role of typical antipsychotics, adjunctive agents, and novel antipsychotic medications in the pharmacological management of persistent aggression in patients with schizophrenia.

Original languageEnglish (US)
Pages (from-to)173-181
Number of pages9
JournalJournal of the American Academy of Psychiatry and the Law
Volume25
Issue number2
StatePublished - Dec 1 1997

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Aggression and schizophrenia: Efficacy of risperidone'. Together they form a unique fingerprint.

  • Cite this

    Buckley, P. F., Ibrahim, Z. Y., Singer, B., Orr, B., Donenwirth, K., & Brar, P. S. (1997). Aggression and schizophrenia: Efficacy of risperidone. Journal of the American Academy of Psychiatry and the Law, 25(2), 173-181.